News Alerts

29 Jul 2020 | 03:46 AM UTC

US: Arriving passengers in Massachusetts and Washington, DC to undergo 14-day quarantine as of July 27 /update 79

United States of America News Alert

Passengers arriving in Washington, DC and Massachusetts to undergo mandatory 14-day quarantine as of July 27 and August 1 respectively; confirm travel itineraries

TIMEFRAME expected from 7/29/2020, 12:00 AM until 8/31/2020, 11:59 PM (America/New_York). COUNTRY/REGION Massachusetts, District of Columbia

Read all related news alert(s):

Event

As of Monday, July 27, passengers arriving in Washington, DC from a high-risk state (within the prior 14 days) who were traveling for non-essential activities will be required to self-quarantine for 14 days from their arrival. Individuals traveling from high-risk states after essential travel or arriving for essential travel are required to self-monitor for symptoms of  coronavirus disease (COVID-19) for 14 days and, if they show signs or experience symptoms of COVID-19, they are to self-quarantine and seek medical advice or testing. A list of high-risk states can be found here

Separately, as of Saturday, August 1, passengers arriving in Massachusetts will have to undergo a mandatory 14-day quarantine. Travelers entering from lower-risk states, travelers who meet the 72-hour negative coronavirus disease (COVID-19) test result rule, and other limited circumstance-specific cases will be exempt from the quarantine order. All the details of the exemptions can be seen here

Numerous US states have imposed quarantine orders on arrivals from other states with high rates of COVID-19 infection, as well as other measures such as bans on large public events and gatherings.

As of Wednesday, July 29, 4,349,313 cases of COVID-19 have been confirmed in the US, with 149,235 associated fatalities. Further international spread of the virus is expected in the near term.

Context

The first case of COVID-19 was reported on December 31 and the source of the outbreak has been linked to a wet market in Wuhan (Hubei province, China). Since then, human-to-human transmission of the virus has been confirmed.

Cases of the virus have been confirmed in numerous countries and territories worldwide. On March 11, the World Health Organization (WHO) declared the global outbreak a pandemic. Virus-screening and quarantining measures are being implemented at airports worldwide, as well as extensive travel restrictions. T

he most common symptoms of COVID-19 are fever, dry cough, and tiredness. Some patients may experience other symptoms such as body pains, nasal congestion, headache, conjunctivitis, sore throat, diarrhea, loss of taste or smell, or a rash on skin or discoloration of fingers or toes. These symptoms (in most cases mild) appear gradually. Generally, most patients (around 80 percent) recover from the disease without being hospitalized.

Advice

Measures adopted by local authorities evolve quickly and are usually effective immediately. Depending on the evolution of the outbreak in other countries, authorities are likely to modify, at very short notice, the list of countries whose travelers are subject to border control measures or entry restrictions upon their arrival to the territory in question. It is advised to postpone nonessential travel due to the risk that travelers may be refused entry or be subject to quarantine upon their arrival or during their stay.

To reduce the risk of COVID-19 transmission, travelers are advised to abide by the following measures:

  • Frequently clean hands by applying an alcohol-based hand rub or washing with soap and water.
  • When coughing and sneezing, cover mouth and nose with a flexed elbow or tissue; if used, throw the tissue away immediately and wash hands.
  • If experiencing a fever, cough, difficulty breathing, or any other symptoms suggestive of respiratory illness, including pneumonia, call emergency services before going to the doctor or hospital to prevent the potential spread of the disease.

 

Copyright and Disclaimer
GardaWorld is the owner or licensee of all intellectual property rights in the material presented on this website. All such rights are reserved. The use of this website and its material is subject to the Terms of Use and accordingly you must not use any content from this website for commercial or other analogous purposes without our consent, including but not limited to any deep-linking or framing in order to copy, distribute, display or monitor any portion of the website. If you have any questions or are interested in distributing any content from this website, Contact us for more details.

Related news